不确定潜能克隆性造血与晚期慢性肾脏病患者肾功能恶化和贫血的相关性:两个队列研究
在兩個獨立隊列(87例和85例eGFR<60 ml/min per 1.73m²的成人)中检测不确定潜能克隆性造血(CHIP)突变,基线CHIP检出率分别为21%和29%。CHIP与更高的肾衰竭风险方程(KFRE)评分、5年内eGFR下降50%或ESKD风险增加(HR 2.2;95%CI 1.2-3.8)以及贫血相关。
要点
- 晚期CKD患者中CHIP检出率约21%-29%,与更高KFRE评分相关。
- CHIP与5年内eGFR下降50%或ESKD风险增加相关(HR 2.2;95%CI 1.2-3.8)。
- CHIP患者血红蛋白更低、铁蛋白更高、红细胞平均体积更高。
核心结论
- 在预先存在CKD的个体中,CHIP与更高的基线KFRE评分、更快的CKD进展和贫血相关。
- 需要进一步研究以明确CHIP与肾脏疾病进展之间关系的性质。
研究设计与样本
- 在两个独立队列(分别87例和85例eGFR<60 ml/min per 1.73m²的成人)中进行靶向测序以检测CHIP突变。
- 基线横断面评估肾功能、血液学和矿物骨病参数,并收集随后5年期间的肌酐测量值。
主要发现
- 基线时,CHIP在87例队列中检出18例(21%),在85例队列中检出25例(29%)。
- 与无CHIP者相比,CHIP患者根据肾衰竭风险方程(KFRE)预测的肾衰竭风险更高。
- 在调整年龄、性别和基线eGFR的Cox比例风险模型中,CHIP患者5年随访期间eGFR下降50%或ESKD的风险增加2.2倍(HR 2.2;95%CI 1.2-3.8)。
- 将CHIP加入2年和5年校准KFRE风险模型改善了ESKD预测。
- 与无CHIP者相比,CHIP患者血红蛋白更低、铁蛋白更高、红细胞平均体积更高。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Clonal hematopoiesis of indeterminate potential (CHIP) is an inflammatory premalignant disorder resulting from acquired genetic mutations in hematopoietic stem cells. This condition is common in aging populations and associated with cardiovascular morbidity and overall mortality, but its role in CKD is unknown. METHODS: We performed targeted sequencing to detect CHIP mutations in two independent cohorts of 87 and 85 adults with an eGFR<60 ml/min per 1.73m2. We also assessed kidney function, hematologic, and mineral bone disease parameters cross-sectionally at baseline, and collected creatinine measurements over the following 5-year period. RESULTS: At baseline, CHIP was detected in 18 of 87 (21%) and 25 of 85 (29%) cohort participants. Participants with CHIP were at higher risk of kidney failure, as predicted by the Kidney Failure Risk Equation (KFRE), compared with those without CHIP. Individuals with CHIP manifested a 2.2-fold increased risk of a 50% decline in eGFR or ESKD over 5 years of follow-up (hazard ratio 2.2; 95% confidence interval, 1.2 to 3.8) in a Cox proportional hazard model adjusted for age, sex, and baseline eGFR. The addition of CHIP to 2-year and 5-year calibrated KFRE risk models improved ESKD predictions. Those with CHIP also had lower hemoglobin, higher ferritin, and higher red blood cell mean corpuscular volume versus those without CHIP. CONCLUSIONS: In this exploratory analysis of individuals with preexisting CKD, CHIP was associated with higher baseline KFRE scores, greater progression of CKD, and anemia. Further research is needed to define the nature of the relationship between CHIP and kidney disease progression.
引用
- Vlasschaert C, McNaughton AJM, Chong M, et al. Association of Clonal Hematopoiesis of Indeterminate Potential with Worse Kidney Function and Anemia in Two Cohorts of Patients with Advanced Chronic Kidney Disease. J Am Soc Nephrol. 2022. PMID: 35197325. doi:10.1681/ASN.2021060774
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。